# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down...
While Schwazze's issue may seem minor compared to past scandals, it serves as a reminder of how easily financial mistakes c...
The Colorado Department of Revenue reported 673 cannabis dispensaries by the end of August, with an average revenue of $162,000...
Removing 280E in 2025 could drastically improve cash flow for cannabis companies. See how major MSOs like Green Thumb, Trulieve...
Viridian Capital Advisors provides cannabis investors with a more comprehensive EV calculation compared to traditional methods.
Benchmark analyst Mike Hickey reiterates Medicine Man Technologies (OTC:SHWZ) with a Buy and maintains $2.5 price target.
Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate...